Moderate-intensity statin therapy combined with ezetimibe reduces new-onset diabetes compared to high-intensity statin therapy in patients undergoing percutaneous coronary intervention
Current assessment
Synthesis pending
Confidence
Not assessed
Supporting evidence (0)
Nothing recorded on this side
Contradicting evidence (0)
Nothing recorded on this side
Discussion (0)
Sign in to join the discussion.
No comments yet
Be the first to weigh in on this evidence.